Skip to main content
Tags: trump | syringes | vaccine | apiject | coronavirus

Trump Administration, Syringe Maker Sign $138M COVID-19 Deal

a needle goes into a baby's arm
A children's doctor injects a vaccine against measles, rubella, mumps and chicken pox to an infant in 2015. (Sean Gallup/Getty Images)

By    |   Tuesday, 12 May 2020 07:07 PM EDT

The Trump administration has signed a $138 million deal with a company that makes inexpensive prefilled syringes while seeking to ramp up the national capacity for a potential COVID-19 vaccine.

The Health and Human Services and Defense departments are partnering with ApiJect Systems America, which makes prefilled syringes that are designed to be used in developing countries, reports NBC News, for a public-private initiative called Project Jumpstart.

The partnership's goal is to facilitate the production of 100 million prefilled syringes by the end of this year and for more than 500 million more syringes in 2021, if a vaccine is developed and approved. 

Defense Department spokesman Lt. Col. Mike Andrews commented that the project will "significantly decrease" the country's dependence on offshore supply chains and older technologies. The devices are to be made in the United States, and plans are already underway to retrofit facilities that produce eyedrops and similar items. ApiJect is also raising money to build new plants, to increase the syringe productions. 

Typically, vaccines are sent out in small glass vials, which require using a syringe to draw out the vaccine. ApiJect, however, skips that step with easy-to-produce plastic syringes. 

“Nobody has ever used an injectable prefilled syringe made of plastic in the tens of millions or even in the millions, because nobody had ever figured out how to attach a needle to a plastic-filled container with a drug,” ApiJect CEO Jay Walker told NBC News. “The technology to attach the two is the key to the uniqueness of what HHS saw we had solved.”

The device has a needle that is easy to attach to a container described as being similar to an eyedropper. Walker said the syringes cost less than $1 each to produce, making them far less expensive to produce than other prefilled syringes or glass vials. 

The device consists of an easy-to-attach needle and a plastic single-use container similar to ones used for eyedrops. The plastic syringes are made through a “Blow-Fill-Seal” manufacturing process, used in high-volume production for pharmaceutical grade products.

The deal comes after HHS in March announced a $456 million grant had been awarded to ApiJect to research and develop the syringes. 

Production is expected to start this October. 

Sandy Fitzgerald

Sandy Fitzgerald has more than three decades in journalism and serves as a general assignment writer for Newsmax covering news, media, and politics. 

© 2024 Newsmax. All rights reserved.


US
The Trump administration has signed a $138 million deal with a company that makes inexpensive prefilled syringes while seeking to ramp up the national capacity for a potential COVID-19 vaccine....
trump, syringes, vaccine, apiject, coronavirus
370
2020-07-12
Tuesday, 12 May 2020 07:07 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
Get the NewsmaxTV App for iOS Get the NewsmaxTV App for Android Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved